BE839744A - Composes a effet anti-depressif et procedes de preparation - Google Patents

Composes a effet anti-depressif et procedes de preparation

Info

Publication number
BE839744A
BE839744A BE165316A BE165316A BE839744A BE 839744 A BE839744 A BE 839744A BE 165316 A BE165316 A BE 165316A BE 165316 A BE165316 A BE 165316A BE 839744 A BE839744 A BE 839744A
Authority
BE
Belgium
Prior art keywords
compounds
preparation
methods
depressive effect
depressive
Prior art date
Application number
BE165316A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE839744A publication Critical patent/BE839744A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE165316A 1975-03-20 1976-03-18 Composes a effet anti-depressif et procedes de preparation BE839744A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
BE839744A true BE839744A (fr) 1976-09-20

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
BE165316A BE839744A (fr) 1975-03-20 1976-03-18 Composes a effet anti-depressif et procedes de preparation

Country Status (27)

Country Link
US (1) US4085225A (cs)
JP (1) JPS6026776B2 (cs)
AR (2) AR211011A1 (cs)
AT (1) AT340895B (cs)
AU (1) AU505358B2 (cs)
BE (1) BE839744A (cs)
CA (1) CA1076142A (cs)
CH (4) CH626057A5 (cs)
DD (1) DD128332A5 (cs)
DE (1) DE2610886A1 (cs)
DK (1) DK144942C (cs)
ES (1) ES446192A1 (cs)
FI (1) FI61875C (cs)
FR (1) FR2304336A1 (cs)
GB (1) GB1535226A (cs)
GR (1) GR60052B (cs)
HU (1) HU171030B (cs)
IE (1) IE43768B1 (cs)
IL (1) IL49238A (cs)
IT (1) IT1063064B (cs)
MX (1) MX9203723A (cs)
NL (1) NL7503310A (cs)
PL (3) PL100052B1 (cs)
SE (1) SE410312B (cs)
SU (3) SU635867A3 (cs)
YU (1) YU39345B (cs)
ZA (1) ZA761434B (cs)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
WO1997006792A1 (en) * 1995-08-16 1997-02-27 Eli Lilly And Company Potentiation of serotonin response
IN182588B (cs) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (cs) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
WO2001078721A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
AU5565401A (en) * 2000-04-24 2001-11-07 Aryx Therapeutics Materials and methods for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
CN1606554B (zh) * 2001-10-12 2013-03-20 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
KR100828218B1 (ko) 2003-09-12 2008-05-07 화이자 인코포레이티드 알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물
CA2547283C (en) * 2003-11-26 2010-11-09 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
JP5646126B2 (ja) 2003-12-11 2014-12-24 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． 鎮静剤と神経伝達物質調節剤の併用、および睡眠の質の向上方法および鬱の治療方法
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
JP2008534504A (ja) 2005-03-22 2008-08-28 アゼヴァン ファーマスーティカルズ，インコーポレイテッド 月経前障害を治療するためのβラクタミルアルカン酸
WO2006116170A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
GT200600164A (es) 2005-04-22 2007-03-14 Derivados de dihidrobenzofuranos y usos de los mismos
BRPI0610785A2 (pt) * 2005-04-22 2016-09-13 Wyeth Corp polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição
CA2605554A1 (en) 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
JP2009500043A (ja) * 2005-07-08 2009-01-08 ブレインセルス，インコーポレイティド 神経新生を調節する薬剤及び条件を同定する方法
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
PL1910346T3 (pl) * 2005-07-19 2019-09-30 Azevan Pharmaceuticals, Inc. Beta-laktamowy antagonista wazopresyny fenyloalaniny, cysteiny i seryny
EP1909777A2 (en) * 2005-07-22 2008-04-16 Myriad Genetics, Inc. High drug load formulations and dosage forms
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1998773A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware New therapeutic combinations for the treatment of depression
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
WO2008086483A2 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011050198A1 (en) 2009-10-23 2011-04-28 Janssen Pharmaceutica Nv Disubstituted octahy - dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
CA2783699C (en) 2009-12-08 2019-01-15 Case Western Reserve University Primary amine compounds for treating ocular disorders
CN107007596A (zh) 2010-07-01 2017-08-04 阿泽凡药物公司 用于治疗创伤后应激障碍的方法
MX2013010598A (es) 2011-03-17 2014-01-08 Lupin Ltd Composiciones farmaceuticas de liberacion controlada de inhibidor de recaptacion de serotonina selectivo.
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
WO2014178064A2 (en) * 2013-04-03 2014-11-06 Zcl Chemicals Limited "an improved process for the preparation of fluvoxamine maleate"
HRP20210114T1 (hr) 2014-02-07 2021-04-16 Támogatott Kutatócsoportok Irodája Nova primjena spoja agonista sigma-1 receptora
PL3122743T3 (pl) 2014-03-28 2023-05-02 Azevan Pharmaceuticals, Inc. Kompozycje i sposoby leczenia chorób neurodegeneracyjnych
JP7066622B2 (ja) * 2016-03-10 2022-05-13 ヤンセン ファーマシューティカ エヌ．ベー． オレキシン－２受容体アンタゴニストを用いてうつ病を治療する方法
MA46898A (fr) 2016-11-24 2019-10-02 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Compositions pour la conservation d'organes
AU2018333051B2 (en) 2017-09-15 2024-03-21 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
CH626057A5 (cs) 1981-10-30
IT1063064B (it) 1985-02-11
AU505358B2 (en) 1979-11-15
DE2610886C2 (cs) 1987-09-24
IE43768L (en) 1976-09-20
PL100052B1 (pl) 1978-08-31
AR211153A1 (es) 1977-10-31
DK144942B (da) 1982-07-12
MX9203723A (es) 1992-07-01
SU645559A3 (ru) 1979-01-30
ZA761434B (en) 1977-10-26
FR2304336B1 (cs) 1979-09-28
YU39345B (en) 1984-10-31
YU71476A (en) 1982-10-31
US4085225A (en) 1978-04-18
NL7503310A (nl) 1976-09-22
SE7603341L (sv) 1976-09-21
CH629184A5 (de) 1982-04-15
CA1076142A (en) 1980-04-22
HU171030B (hu) 1977-10-28
CH629477A5 (de) 1982-04-30
FI61875C (fi) 1982-10-11
ATA195476A (de) 1977-05-15
AT340895B (de) 1978-01-10
GR60052B (en) 1978-04-04
SU635867A3 (ru) 1978-11-30
CH629761A5 (de) 1982-05-14
PL100614B1 (pl) 1978-10-31
DK115976A (da) 1976-09-21
DE2610886A1 (de) 1976-10-07
IE43768B1 (en) 1981-05-20
FR2304336A1 (fr) 1976-10-15
SU620206A3 (ru) 1978-08-15
DD128332A5 (de) 1977-11-09
JPS6026776B2 (ja) 1985-06-25
JPS51125345A (en) 1976-11-01
AR211011A1 (es) 1977-10-14
ES446192A1 (es) 1977-10-01
SE410312B (sv) 1979-10-08
IL49238A (en) 1978-08-31
IL49238A0 (en) 1976-05-31
FI61875B (fi) 1982-06-30
PL101951B1 (pl) 1979-02-28
FI760699A7 (cs) 1976-09-21
DK144942C (da) 1982-12-06
GB1535226A (en) 1978-12-13
AU1214776A (en) 1977-09-22

Similar Documents

Publication Publication Date Title
FR2304336A1 (fr) Composes a effet anti-depressif et procedes de preparation
FR2316201A1 (fr) Similigranite et sa preparation
FR2338251A1 (fr) Nouveau compose peptidique et sa preparation
FR2296654A1 (fr) Polycarbonates thermoplastiques ramifies et leur preparation
MX143009A (es) Cateter mejorado
FR2333519A1 (fr) Catheter uretral
BE857558A (fr) Amelioration des catheters
FR2313685A1 (fr) Hydrophone perfectionne insensible aux accelerations
SE433092B (sv) Forfarande for forvermning och patentering samt streckning av en staltrad
NO143350C (no) 3-oximer av d-17alfa-etynyl-19-nortestosteronestere med befruktningshindrende virkning
BE853418A (fr) Articles a fumer et procede de preparation
SE7606366L (sv) Kateter
FR2345439A1 (fr) Dihydrooxadiazinones et leurs procedes de preparation
AU499080B2 (en) Ortho-aminobutyrophenone derivatives and salts thereof
BE840866A (fr) Composition therapeutique a activite anti-agregante plaquettaire
FR2318863A1 (fr) Bestatine et ses derives
FR2301511A1 (fr) Pentafluorsethylarylamines et leurs procedes de preparation
SE7604448L (sv) Diastereoisomerer av fenylaminoetanol-derivat
DK122576A (da) Signalspidsverdidetektor
BE861351A (fr) Composes alcanoylanilides et leur preparation
SE7609623L (sv) Framstellning av nikotinamid
FR2319351A1 (fr) Hydantoines et procedes d'obtention
AU510882B2 (en) Esters of naphthyl allohols
FR2304335A1 (fr) Composes a effet anti-depressif
FR2301249A1 (fr) Derives du 3-amino-4-carbamyl-pyrrole et leur preparation

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0058

CCPV Grant of a supplementary protection certificate

Free format text: 093C0058, EXPIRES 19990103

RE20 Patent expired

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V.

Effective date: 19960318